What stage does Aurora Science invest at?

Aurora Science invests at the Pre-Seed, Seed stages.

What sectors does Aurora Science focus on?

Aurora Science focuses on Biotech, Healthtech.

Where is Aurora Science located?

Aurora Science is headquartered in Milano, IT.

Aurora Science

Venture capital

Milano · Pre-Seed–Seed · 5 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Aurora Science

Paths you didn't know you had: your email and LinkedIn already hold routes to the Aurora Science team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

AurorA Science operates at the intersection of venture capital and translational medicine in the bio-pharma sector. It draws on the AurorA-TT team's operational and technology-transfer experience alongside the in-house R&D capabilities and drug development know-how of its strategic industrial partners, Rottapharm Biotech and Italfarmaco. This structure positions the firm to support the development and partnering of bio-pharma companies.

Invests inBiotech Healthtech Europe Italy Milan Milano

Source: firm website, verified Sep 26, 2026.

Leave your own feedback

Stage

Pre-Seed–Seed

Milano, IT

Instruments

Equity

Founded

2014

Tracked investments

Team · 5 people

from the firm's website

Paolo Rizzardi· Co-Founder & Managing Partner· Seattle, Washington, United Statesin

Physician and internist, co-founder and managing partner of AurorA-TT and co-founder, chairman and CEO of Altheia Science. He has extensive academic and biotech experience in cell and gene therapy and oncology, spanning R&D through market approval.

Pierluigi Paracchi· Co-Founder & Venture Consultant· Indonesiain

Co-founder and venture consultant of AurorA-TT and co-founder of Altheia Science, with more than 15 years as a venture capitalist and biotech entrepreneur. He founded Quantica, was venture consultant at Sofinnova Partners, and is co-founder and CEO of Genenta Science.

Gabriele Campi· Immunologist / Technology Transfer· New York, New York, United Statesin

Immunologist with over a decade of academic research at San Raffaele Hospital and NYU, plus six-plus years in venture capital and technology transfer across Italy, Switzerland, and the UK, including work at TTFactor (IEO/IFOM).

Francesco De Santis· President, Italfarmaco Holding SpA

President of Italfarmaco Holding since 1995 and former Vice-President of Farmindustria, with roles across pharmaceutical industry bodies and scientific academic institutions.

Lucio Rovati· CEO & Chief Scientific Officer, Rottapharm Biotech· Milan

Physician specialized in clinical pharmacology with extensive clinical research experience across multiple therapeutic areas. He founded Rottapharm Biotech in 2014 and serves as its CEO and CSO, and is an invited professor of clinical pharmacology at the University of Milano-Bicocca.

What they invest in

from 3 of 3 portfolio companies

Biotech ×3Deep Tech ×3Medical Devices ×2AI & Machine Learning ×1Healthtech ×1

HQs:Spain×1Netherlands×1

Investments · 3 tracked

founders shown can be your intro path

Aglaia Oncology Fundsaglaia-oncology.com

Aglaia is an investment firm specializing in early-stage oncology drug development companies, selecting and maturing breakthrough inventions with potential to transform cancer treatment.

BiotechDeep Tech

Co-investorsBOM Cathay Venture Korys Oost NL

InteRNAinterna.bio

Interna develops a molecular delivery platform that transports large molecule therapeutics such as DNA, RNA, and proteins across cell membranes to treat infectious and non-infectious diseases.

AI & Machine LearningBiotechDeep TechMedical Devices

Roger D. Kornberg(Scientific Leader)

Co-investorsInkef

Peptomycpeptomyc.com in 𝕏Dec 2020

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.

BiotechDeep TechHealthtechMedical DevicesBarcelona, ES

Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))in

Co-investorsAsabys Partners Invivo Capital Partners Alta Life Sciences

Frequently asked questions

What stage does Aurora Science invest at?: Aurora Science invests at the Pre-Seed, Seed stages.
What sectors does Aurora Science focus on?: Aurora Science focuses on Biotech, Healthtech.
Where is Aurora Science located?: Aurora Science is headquartered in Milano, IT.

Images

Similar investors

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$500K – $50M

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Blackbird Ventures

Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.

$149K – $60M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M